Apology and Notice
Thank you very much for your continued patronage.
In order to eliminate misconceptions by general consumers in accordance with the Order of Measures by the Consumer Affairs Agency based on the provisions of Article 7, Paragraph 1 of the Act on Prevention of Improper Gifts and Improper Labeling (Premium Labeling Act), we have made the following notices. I will.
Our company
In selling 18 products (this product) including "Mask for changing pollen into water + 4 Mask with cloudy weather (normal)", in each container and packaging, from January 2018,
"+4 Pollen Countermeasures Decomposition Power Regular", "Mask that turns pollen * into water", "* Decomposes protein in pollen", "Hydrosilver titanium born from a new idea of doctors"
®(Hyd [AgTiO2]) technology is used to decompose proteins such as pollen / house dust / mold and sweat * / smell * / unhygienic proteins into water, DR. This is a clean technology unique to C medicine. "," * Decomposes sweat and odor proteins, "etc., it is as if the product were installed, due to the effect of the hydrosilver titanium contained in this product, pollen, house dust and Is it possible to prevent the inhalation of these substances by chemically decomposing substances that cause allergies and malodors that are derived from molds into water? It was displayed as follows.
Regarding such labeling, we submitted various materials in response to a request from the Consumer Affairs Agency based on the provisions of Article 7 Paragraph 2 of the Premium Labeling Law, but it does not indicate that it is a reasonable basis to support the labeling. It is judged that it is not allowed, and the display made regarding the transaction of this product shows that the content of this product is significantly better than the actual one to the general consumer, and it violates the prize labeling law. It did.
We deeply apologize for the inconvenience caused to our customers and everyone involved. We will take this measure order seriously, review the labeling method of advertisements and containers and packaging, and strive to further strengthen the management system to prevent recurrence. We appreciate your understanding.
December 18, 2019
DR. C Pharmaceutical Co., Ltd.
Representative Director Shigemi Okazaki